Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$0.85 - $1.26 $25,929 - $38,436
-30,505 Reduced 50.58%
29,811 $29,000
Q1 2024

May 14, 2024

BUY
$0.91 - $1.75 $15,729 - $30,248
17,285 Added 40.17%
60,316 $77,000
Q2 2023

Aug 11, 2023

BUY
$2.79 - $5.03 $31,409 - $56,627
11,258 Added 35.43%
43,031 $141,000
Q4 2022

Aug 11, 2023

BUY
$5.77 - $8.49 $10,743 - $15,808
1,862 Added 6.23%
31,773 $219,000
Q4 2022

Feb 13, 2023

BUY
$5.77 - $8.49 $10,743 - $15,808
1,862 Added 6.23%
31,773 $219,000
Q3 2022

Aug 11, 2023

SELL
$3.75 - $7.39 $4,695 - $9,252
-1,252 Reduced 4.02%
29,911 $189,000
Q3 2022

Nov 03, 2022

SELL
$3.75 - $7.39 $4,695 - $9,252
-1,252 Reduced 4.02%
29,911 $189,000
Q2 2022

Aug 11, 2023

BUY
$2.94 - $5.23 $4,265 - $7,588
1,451 Added 4.88%
31,163 $129,000
Q2 2022

Aug 15, 2022

BUY
$2.94 - $5.23 $4,265 - $7,588
1,451 Added 4.88%
31,163 $129,000
Q1 2022

Aug 11, 2023

SELL
$4.07 - $10.6 $8,388 - $21,846
-2,061 Reduced 6.49%
29,712 $144,000
Q1 2022

May 20, 2022

SELL
$4.07 - $10.6 $26,235 - $68,327
-6,446 Reduced 17.83%
29,712 $144,000
Q4 2021

Feb 16, 2022

BUY
$8.96 - $16.31 $3,843 - $6,996
429 Added 1.2%
36,158 $361,000
Q3 2021

Nov 12, 2021

SELL
$11.24 - $21.0 $26,267 - $49,077
-2,337 Reduced 6.14%
35,729 $442,000
Q2 2021

Aug 12, 2021

BUY
$18.04 - $22.09 $686,710 - $840,877
38,066 New
38,066 $1.22 Million
Q3 2018

Nov 14, 2018

SELL
$88.86 - $117.49 $116,495 - $154,029
-1,311 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$99.64 - $127.59 $3.46 Million - $4.43 Million
-34,725 Reduced 96.36%
1,311 $206,000
Q1 2018

May 15, 2018

SELL
$105.8 - $150.94 $93,421 - $133,280
-883 Reduced 2.39%
36,036 $6.15 Million
Q4 2017

Feb 08, 2018

BUY
$81.25 - $130.7 $205,318 - $330,278
2,527 Added 7.35%
36,919 $6.58 Million
Q3 2017

Nov 14, 2017

BUY
$57.74 - $91.42 $1.99 Million - $3.14 Million
34,392
34,392 $4.72 Million

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $27M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.